**Core Concept**
Lupus Anticoagulant (LA) is an autoantibody that inhibits the coagulation pathway, particularly the intrinsic pathway, by binding to phospholipid-binding proteins. This leads to a paradoxical prothrombotic state despite its name. LA is associated with an increased risk of thrombotic events, such as deep vein thrombosis, pulmonary embolism, and stroke.

**Why the Correct Answer is Right**
The correct answer, **Option D**, is incorrect because thrombotic events associated with Lupus Anticoagulant are typically not followed by severe, life-threatening hemorrhage. In fact, the prothrombotic state induced by LA increases the risk of thrombotic complications, rather than bleeding. This is because the autoantibody inhibits the coagulation pathway, leading to a hypercoagulable state.

**Why Each Wrong Option is Incorrect**
**Option A:** While Lupus Anticoagulant can present with an isolated prolongation of Activated Partial Thromboplastin Time (APTT), it is often accompanied by other clinical manifestations, such as thrombocytopenia, renal dysfunction, or neurological symptoms.

**Option B:** Lupus Anticoagulant is indeed associated with an increased risk of recurrent miscarriages, particularly in the presence of other autoimmune disorders. This is thought to be due to the prothrombotic state induced by the autoantibody.

**Option C:** Lupus Anticoagulant can occur with minimal clinical manifestations, and some individuals may be asymptomatic despite the presence of the autoantibody.

**Clinical Pearl / High-Yield Fact**
Lupus Anticoagulant is a significant risk factor for thrombotic events, and its presence should prompt a thorough evaluation for underlying autoimmune disorders, such as Systemic Lupus Erythematosus (SLE).

**✓ Correct Answer: D. Thrombotic spells can be followed by severe life threatening hemorrhage**